TP53 and neoplasm: Molecular analyses in CMV-positive rate subgroups have shown that the expression of CMV-IE was significantly associated with p53 mutations, telomerase activity, and several proto-oncogenes, resulting in a more aggressive tumor phenotype [31,33,34,35].